Testing effectiveness (Phase 2)Study completedNCT01867294
What this trial is testing
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Who this might be right for
Advanced Malignant NeoplasmDermatologic Complication
Academic and Community Cancer Research United 19